Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00027162%3A_____%2F18%3AN0000061" target="_blank" >RIV/00027162:_____/18:N0000061 - isvavai.cz</a>
Result on the web
<a href="http://journals.sagepub.com/doi/10.1177/2040206618761299" target="_blank" >http://journals.sagepub.com/doi/10.1177/2040206618761299</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1177/2040206618761299" target="_blank" >10.1177/2040206618761299</a>
Alternative languages
Result language
angličtina
Original language name
Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses
Original language description
Nucleoside analogs represent the largest class of small molecule-based antivirals, which currently form the backbone of chemotherapy of chronic infections caused by HIV, hepatitis B or C viruses, and herpes viruses. High antiviral potency and favorable pharmacokinetics parameters make some nucleoside analogs suitable also for the treatment of acute infections caused by other medically important RNA and DNA viruses. This review summarizes available information on antiviral research of nucleoside analogs against arthropod-borne members of the genus Flavivirus within the family Flaviviridae, being primarily focused on description of nucleoside inhibitors of flaviviral RNA-dependent RNA polymerase, methyltransferase, and helicase/NTPase. Inhibitors of intracellular nucleoside synthesis and newly discovered nucleoside derivatives with high antiflavivirus potency, whose modes of action are currently not completely understood, have drawn attention. Moreover, this review highlights important challenges and complications in nucleoside analog development and suggests possible strategies to overcome these limitations.
Czech name
—
Czech description
—
Classification
Type
J<sub>SC</sub> - Article in a specialist periodical, which is included in the SCOPUS database
CEP classification
—
OECD FORD branch
10607 - Virology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Antiviral Chemistry and Chemotherapy
ISSN
2040-2066
e-ISSN
—
Volume of the periodical
26
Issue of the periodical within the volume
March
Country of publishing house
GB - UNITED KINGDOM
Number of pages
28
Pages from-to
2040206618761299
UT code for WoS article
—
EID of the result in the Scopus database
2-s2.0-85045317817